Synerkine Pharma BV
Desconocido
BonePainIII: Identifying mechanisms and novel treatments of bone pain – closing the gap to the clinic.
Synerkine Pharma BV
participó en un
HORIZON EUROPE:
HORIZON-MSCA-2022-DN-01
Musculoskeletal pain from diseases such as arthritis and cancer in the bone affects the quality of life of millions and is a major societal...
2023-07-14 - 2027-12-31 | Financiado
2023-07-14 - 2027-12-31 | Financiado
* No se disponen de datos de la empresa actual.